Multimarker model for non-invasive assessment of variceal bleeding in chronic hepatitis C cirrhotic patients

Table 3 Thyroid function tests across study groups, mean ± SD

Parameter	Group I (n = 31)	Group II (n = 31)	Group III (n = 31)	P value (I vs II)1	P value (I vs III)1	P value (II vs III)1
TSH (μIU/mL)	1.22 ± 1.47	1.41 ± 1.75	1.70 ± 1.40	0.65 (NS)	0.47 (NS)	0.72 (NS)
FT3 (pmol/L)	2.34 ± 0.53	2.62 ± 0.68	4.05 ± 0.58	0.83 (NS)	< 0.01 (HS)	< 0.01 (HS)
FT4 (pmol/L)	14.35 ± 2.87	13.22 ± 5.48	15.29 ± 2.28	0.31 (NS)	0.15 (NS)	0.06 (NS)

¹Comparisons were performed using one-way analysis of variance followed by pairwise comparisons performed using Scheffe’s post-hoc test.

NS: Not significant; HS: Highly significant; TSH: Thyroid-stimulating hormone; FT3: Free triiodothyronine; FT4: Free thyroxine.